Insider · CIK 0001513900

COLVIN PAUL

Reports to the SEC for 2 companies · WILMINGTON, NC

sec.gov

Transactions

Companies

Filings

CIK

0001513900

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-03-02	Syneos Health, Inc.A Award	Pres., Clinical Solutions	AAward	+1,048 sh	—	—	30,952
2021-03-02	Syneos Health, Inc.A Award	Pres., Clinical Solutions	AAward	+1,629 sh	—	—	29,904
2021-02-01	Syneos Health, Inc.S Sale	Pres., Clinical Solutions	SSale	−8,486 sh	$74.82	−$635K	28,275
2021-01-15	Syneos Health, Inc.F Tax Payment	Pres., Clinical Solutions	FTax Payment	−1,768 sh	$75.42	−$133K	25,298
2021-01-15	Syneos Health, Inc.A Award	Pres., Clinical Solutions	AAward	+11.5K sh	—	—	36,761
2021-01-08	Syneos Health, Inc.F Tax Payment	Pres., Clinical Solutions	FTax Payment	−2,031 sh	$73.59	−$149K	27,066
2021-01-02	Syneos Health, Inc.F Tax Payment	Pres., Clinical Solutions	FTax Payment	−249 sh	$67.36	−$16.8K	29,097
2020-03-19	Syneos Health, Inc.P Purchase	Pres., Clinical Solutions	PPurchase	+1,300 sh	$36.65	+$47.6K	26,855
2020-03-05	Syneos Health, Inc.A Award	Pres., Clinical Solutions	AAward	+2,491 sh	—	—	29,346
2020-01-15	Syneos Health, Inc.A Award	Pres., Clinical Solutions	AAward	+11.9K sh	—	—	25,555
2020-01-08	Syneos Health, Inc.F Tax Payment	Pres., Clinical Solutions	FTax Payment	−1,404 sh	$59.96	−$84.2K	13,693
2020-01-02	Syneos Health, Inc.F Tax Payment	Pres., Clinical Solutions	FTax Payment	−249 sh	$59.51	−$14.8K	15,097
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)D Disposition to Issuer	EVP--Clinical Development	DDisposition to Issuer	−16K sh	—	—	0
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)D Disposition to Issuer	EVP--Clinical Development	DDisposition to Issuer	−16K sh	—	—	0
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)D Disposition to Issuer	EVP--Clinical Development	DDisposition to Issuer	−15.5K sh	—	—	0
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)D Disposition to Issuer	EVP--Clinical Development	DDisposition to Issuer	−30K sh	—	—	0
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCRestricted Stock UnitsD Disposition to Issuer	EVP--Clinical Development	DDisposition to Issuer	−10K sh	—	—	0
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)D Disposition to Issuer	EVP--Clinical Development	DDisposition to Issuer	−11.4K sh	—	—	0
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)D Disposition to Issuer	EVP--Clinical Development	DDisposition to Issuer	−31.1K sh	—	—	0
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCD Disposition to Issuer	EVP--Clinical Development	DDisposition to Issuer	−45 sh	$33.25	−$1,496.25	0
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)D Disposition to Issuer	EVP--Clinical Development	DDisposition to Issuer	−3,753 sh	—	—	0
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)D Disposition to Issuer	EVP--Clinical Development	DDisposition to Issuer	−11K sh	—	—	0
2011-11-22	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCI Discretionary Transaction	EVP--Clinical Development	IDiscretionary Transaction	+20 sh	$24.98	+$499.6	45
2011-06-30	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCI Discretionary Transaction	EVP--Clinical Development	IDiscretionary Transaction	+24 sh	$24.16	+$579.84	24
2011-05-27	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCM Exercise/Conversion	EVP--Clinical Development	MExercise/Conversion	+326 sh	$19.94	+$6,500.44	326
2011-05-27	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCM Exercise/Conversion	EVP--Clinical Development	MExercise/Conversion	+5,333 sh	$20.45	+$109K	5,659
2011-05-27	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion	EVP--Clinical Development	MExercise/Conversion	−5,333 sh	—	—	11,041
2011-05-27	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	EVP--Clinical Development	SSale	−5,659 sh	$28.70	−$162K	0
2011-05-27	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion	EVP--Clinical Development	MExercise/Conversion	−326 sh	—	—	3,753
2011-05-26	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCM Exercise/Conversion	EVP--Clinical Development	MExercise/Conversion	+100 sh	$19.94	+$1,994	100
2011-05-26	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion	EVP--Clinical Development	MExercise/Conversion	−100 sh	—	—	4,079
2011-05-26	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	EVP--Clinical Development	SSale	−100 sh	$28.70	−$2,870	0
2011-05-20	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion	EVP--Clinical Development	MExercise/Conversion	−187 sh	—	—	16,374
2011-05-20	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCM Exercise/Conversion	EVP--Clinical Development	MExercise/Conversion	+413 sh	$19.94	+$8,235.22	413
2011-05-20	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCM Exercise/Conversion	EVP--Clinical Development	MExercise/Conversion	+187 sh	$20.45	+$3,824.15	600
2011-05-20	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	EVP--Clinical Development	SSale	−600 sh	$29.01	−$17.4K	0
2011-05-20	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion	EVP--Clinical Development	MExercise/Conversion	−413 sh	—	—	4,179
2011-02-23	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCRestricted Stock UnitsA Award	EVP--Clinical Development	AAward	+10K sh	—	—	10,000
2011-02-23	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)A Award	EVP--Clinical Development	AAward	+30K sh	—	—	30,000

Recent filings

Accepted (ET)
Mar 44
COLVIN PAUL0001209191-21-017925
SEC(opens sec.gov)
Feb 34
COLVIN PAUL0001209191-21-007350
SEC(opens sec.gov)
Jan 204
COLVIN PAUL0001209191-21-004367
SEC(opens sec.gov)
Jan 114
COLVIN PAUL0001209191-21-002978
SEC(opens sec.gov)
Jan 54
COLVIN PAUL0001209191-21-001249
SEC(opens sec.gov)
Apr 154
COLVIN PAUL0001610950-20-000073
SEC(opens sec.gov)
Mar 234
COLVIN PAUL0001513900-20-000002
SEC(opens sec.gov)
Jan 174
COLVIN PAUL0001610950-20-000022
SEC(opens sec.gov)
Jan 94
COLVIN PAUL0001610950-20-000013
SEC(opens sec.gov)
Jan 34
COLVIN PAUL0001610950-20-000002
SEC(opens sec.gov)
Dec 64
COLVIN PAUL0001513900-11-000006
SEC(opens sec.gov)

Companies

Address

929 NORTH FRONT STREET

WILMINGTON, NC, 28401